WCO classification path
- Chapter30Pharmaceutical products
- Heading3002Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and ether similar products; cell cultures, whether or not modified
- Subheading300213Immunological products, unmixed, not put up in measured doses or in forms or packings for retail sale
- National30021300Immunological products, unmixed, not put up in measured doses or in forms or packings for retail sale
30021300
"Immunological products, unmixed, not put up in measured doses or in forms or packings for retail sale"
HS code 3002130000 (Chapter 30 "Pharmaceutical products"; Heading 3002 "Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and ether similar products; cell cultures, whether or not modified"; Subheading 300213 "Immunological products, unmixed, not put up in measured doses or in forms or packings for retail sale") under the Korea tariff schedule classifies "Immunological products, unmixed, not put up in measured doses or in forms or packings for retail sale". Korea customs apply MFN rate of 0, WTO bound rate 0. Statutory unit of measure: KG. This commodity is subject to 3 import regulations or restrictions; see compliance section below. 31 free trade agreement preferential rates are available for this code.
Tariff Schedule
| Classification | Rate |
|---|---|
MFN 税率 MFN rate | 0 |
WTO 约束税率 WTO bound rate | 0 |
FTA Preferential Rates
31 agreements available · certificate of origin required
| Agreement | Rate |
|---|---|
| KAFTA (Korea-Australia) | 0% |
| CKFTA (Canada-Korea) / CPTPP | 0% |
| Korea-Central America (Costa Rica) | 0% |
| Korea-Central America (Honduras) | 0% |
| Korea-Central America (Nicaragua) | 0% |
| Korea-Central America (Panama) | 0% |
| Korea-Central America (El Salvador) | 0% |
| Korea-Chile | 0% |
| Korea-China | 0% |
| Korea-Colombia | 0% |
| Korea-EFTA | 0% |
| Korea-EU | 0% |
| Korea-UK | 0% |
| Korea-Indonesia (CEPA) | 0% |
| Korea-Israel | 0% |
| Korea-India (CEPA) | 0% |
| Korea-New Zealand | 0% |
| Korea-Peru | 0% |
| Korea-Philippines | 0% |
| RCEP (ASEAN) | 0% |
| RCEP (Australia) | 0% |
| RCEP (China) | 0% |
| RCEP (Japan) | 0% |
| RCEP (New Zealand) | 0% |
| Korea-Singapore | 0% |
| Korea-Turkey | 0% |
| KORUS (Korea-US) | 0% |
| Korea-Vietnam | 0% |
| RCEP | 0% |
| AKFTA (ASEAN-Korea) | 5% |
| Korea-Cambodia | 5% |
Compliance & Controls
3 import regulations, restrictions, or permit requirements
가축전염병 예방법
동물검역증명서
화장품법
표준통관예정보고서(화장품)
약사법
표준통관예정보고서(의약품등)
Global Benchmark
HS-6 prefix 3002.13 across other jurisdictions